Deal flow picked up from already high levels, but returns were light in a ten-IPO week, just the second since 2007. Half of the week’s deals were from financial companies, while the largest was a $947 million offering from Quintiles Transnational (Q), a...read more
Seven deals began trading on Thursday, marking the most US IPOs to debut in a day since December 15, 2004. Thursday's group included single-family residential REIT American Residential Properties (ARPI), packet-optical networking vendor Cyan (CYNI), frac...read more
Receptos, a biotech developing treatments for relapsing multiple sclerosis and IBD, raised $73 million by offering 5.2 million shares (up from 4.7 million) at $14, the low end of the range of $14 to $16. Receptos plans to list on the NASDAQ under the symbol RCPT...read more
US IPO Recap: Ten deals price, highest weekly total since 2010
Deal flow picked up from already high levels, but returns were light in a ten-IPO week, just the second since 2007. Half of the week’s deals were from financial companies, while the largest was a $947 million offering from Quintiles Transnational (Q), a...read more
Seven US IPOs debut on Thursday, most in a single day since 2004
Seven deals began trading on Thursday, marking the most US IPOs to debut in a day since December 15, 2004. Thursday's group included single-family residential REIT American Residential Properties (ARPI), packet-optical networking vendor Cyan (CYNI), frac...read more
Receptos prices upsized IPO at $14, the low end of the range
Receptos, a biotech developing treatments for relapsing multiple sclerosis and IBD, raised $73 million by offering 5.2 million shares (up from 4.7 million) at $14, the low end of the range of $14 to $16. Receptos plans to list on the NASDAQ under the symbol RCPT...read more
13 US IPOs planned for the week of May 6
The following IPOs are expected to price this week: American Residential Properties (ARPI), an internally managed REIT focused on leasing single-family residential...read more